Abiomed (ABMD) Posts Q4 EPS of $0.70
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts ABMD Hot Sheet
Price: $381.02 --0%
Financial Fact:
Other (expense) income, net: -114K
Today's EPS Names:
CIX, ARIS, COHR, More
Financial Fact:
Other (expense) income, net: -114K
Today's EPS Names:
CIX, ARIS, COHR, More
Join SI Premium – FREE
Abiomed (NASDAQ: ABMD) reported Q4 EPS of $0.70, which may not compare to the analyst estimate of $0.94. Revenue for the quarter came in at $206.7 million versus the consensus estimate of $207.17 million.
For earnings history and earnings-related data on Abiomed (ABMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ardent Health Partners, Inc. (ARDT) Tops Q3 EPS by 8c; offers guidance
- Ship Finance (SFL) Tops Q3 EPS by 14c
- CompX International (CIX) Reports Q3 EPS of $0.44
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
